Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients

Experimental Dermatology

Volumn 18, Issue 5, 2009, Pages 485-487

  Council, M Laurin ^a   Gardner, Jennifer M ^a   Helms, Cynthia ^a   Liu, Ying ^a   Cornelius, Lynn A ^a   Bowcock, Anne M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MELANOCORTIN 1 RECEPTOR; MONOPHENOL MONOOXYGENASE;

ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MELANOMA; SKIN CANCER; UNITED STATES;

CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HOMOZYGOTE; HUMANS; INTRONS; MELANOMA; MUTATION; RECEPTOR, MELANOCORTIN, TYPE 1; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UNITED STATES;

EID: 65249108089     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00807.x     Document Type: Article

References (26)

1. Markovic S N, Erickson L A, Rao R D et al. Malignant melanoma in the 21st century, part 1: Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007: 82: 364-380.
2. Hansson J. Familial melanoma. Surg Clin North Am 2008: 88: 897-916.
3. Hussussian C J, Struewing J P, Goldstein A M et al. Germline p16 mutations in familial melanoma. Nat Genet 1994: 8: 15-21.
4. Goldstein A M, Chan M, Harland M et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Research 2006: 9818-9828.
5. Zuo L, Weger J, Yang Q et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996: 12: 97-99.
6. Soufir N, Avril M F, Chompret A et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Hum Mol Genet 1998: 7: 209-216.
7. Molven A, Grimstvedt M B, Steine S J et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 2005: 44: 10-18.
8. Pjanova D, Engele L, Randerson-Moor J A et al. CDKN2A and CDK4 variants in Latvian melanoma patients: Analysis of a clinic-based population. Melanoma Res 2007: 17: 185-191.
9. Fargnoli M C, Altobelli E, Keller G, Chimenti S, Hofler H, Peris K. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: A case-control study. Melanoma Res 2006: 16: 175-182.
10. Bastiaens M T, ter Huurne J A, Kielich C et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Hum Genet 2001: 68: 884-894.
11. Dwyer T, Stankovich J M, Blizzard L et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 2004: 159: 826-833.
12. Brudnik U, Branicki W, Wojas-Pelc A, Kanas P. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population. Exp Dermatol 2008: July 17, 2008. [Epub ahead of print].
13. Box N F, Duffy D L, Chen W et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001: 69: 765-773.
14. Gudbjartsson D F, Sulem P, Stacey S N et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 2008: 40: 886-891.
15. Brown K M, Macgregor S, Montgomery G W et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 2008: 40: 838-840.
16. Holland E A, Schmid H, Kefford R F, Mann G J. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas. Genes Chromosomes Cancer 1999: 25: 339-348.
17. Harland M, Mistry S, Bishop D T, Bishop J A. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet 2001: 10: 2679-2686.
18. Branicki W, Brudnik U, Kupiec T, Wolanska-Nowak P, Wojas-Pelc A. Determination of phenotype associated SNPs in the MC1R gene. J Forensic Sci 2007: 52: 349-354.
19. Matichard E, Verpillat P, Meziani R et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 2004: 41: e13.
20. Ringholm A, Klovins J, Rudzish R, Phillips S, Rees J L, Schioth H B. Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 2004: 123: 917-923.
21. Schioth H B, Phillips S R, Rudzish R, Birch-Machin M A, Wikberg J E, Rees J L. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 1999: 260: 488-491.
22. John P R, Ramsay M. Four novel variants in MC1R in red-haired South African individuals of European descent: S83P, Y152X, A171D, P256S. Hum Mutat 2002: 19: 461-462.
23. Jimenez-Cervantes C, Germer S, Gonzalez P, Sanchez J, Sanchez C O, Garcia-Borron J C. Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor. FEBS Lett 2001: 508: 44-48.
24. Beaumont K A, Newton R A, Smit D J, Leonard J H, Stow J L, Sturm R A. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet 2005: 14: 2145-2154.
25. Goldstein A M, Landi M T, Tsang S, Fraser M C, Munroe D J, Tucker M A. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 2005: 14: 2208-2212.
26. Goldstein A M, Chaudru V, Ghiorzo P et al. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries. Int J Cancer 2007: 121: 825-831.